In liver cancer cells, studies have revealed that the overexpression of DND1 can suppress the characteristics of liver cancer stem cells, impede spheroid formation, restrain epithelial-mesenchymal transformation, and enhance the sensitivity of liver cancer cells to sorafenib therapy (Weiling et al. 2017). This evidence concerns the gene DND1 and liver cancer.